Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting
HINGHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq:MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, announced that Harel Gadot, Chairman, CEO and President, Dr. Eyal Morag, Chief Medical Officer, and other leaders from the business team, will be attending the upcoming Society of Interventional Radiologist (SIR) annual meeting. The Company is meeting with potential strategic and commercial partners as well as leading interventional radiologists, looking to further expand its network of Key Opinion Leaders while also sharing the progress of the LIBERTY Robotic System as it gets closer to commercialization.
Related news for (MBOT)
- Midday Market Wrap: Spider Silk Strength, Robotics Surge & Autonomous Acceleration Fuel the Afternoon Trade
- Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
- 24/7 Market News Snapshot 08 September, 2025 – Microbot Medical, Inc. Common Stock (NASDAQ:MBOT)
- MoBot alert highlights: NASDAQ: OCTO, NASDAQ: AREB, NASDAQ: CDT, NASDAQ: ACRV, NASDAQ: MBOT (09/08/25 06:00 AM)
- MoBot alert highlights: NASDAQ: AREB, NASDAQ: CDT, NASDAQ: OCTO, NASDAQ: ACRV, NASDAQ: MBOT (09/08/25 05:00 AM)